- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 9, 2023
Emerging Company Profile
OrsoBio: bringing obesity mechanisms to bear
Samsara-incubated company garners $60M series A to advance multi-target pipeline assembled via in-licensing
BioCentury | Mar 10, 2016
Distillery Therapeutics
Therapeutics: Carnitine palmitoyl transferase 1 (CPT1); CPT2; v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc)
Items per page:
1 - 9 of 9